0001104659-22-065285.txt : 20220526 0001104659-22-065285.hdr.sgml : 20220526 20220526162415 ACCESSION NUMBER: 0001104659-22-065285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220525 FILED AS OF DATE: 20220526 DATE AS OF CHANGE: 20220526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhou Quan CENTRAL INDEX KEY: 0001491503 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 22970440 MAIL ADDRESS: STREET 1: C/O IDG VC MANAGEMENT LTD. STREET 2: UNIT 1509, THE CENTER, 99 QUEEN'S RD CITY: CENTRAL STATE: K3 ZIP: - ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 4 1 tm2214966d2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-05-25 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001491503 Zhou Quan CASI PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DR. SUITE 300 ROCKVILLE MD 20850 1 0 0 0 Stock Option (Right to Buy) 0.4664 2022-05-25 4 A 0 380645 0 A 2032-05-25 Common Stock 380645 380645 D Stock option award will vest ratably quarterly to the end of the year. Ex 24 - Power of Attorney /s/Alexander A. Zukiwski, attorney-in-fact for Quan Zhou 2022-05-26 EX-24 2 tm2214966d2_ex24.htm EXHIBIT 24

Exhibit 24

CONFIRMING STATEMENT

This Statement confirms that the undersigned, Quan Zhou, has authorized and designated each of Larry Zhang and Alexander Zukiwski to execute and file on the undersigned's behalf Form 3, and all Forms 4 and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of CASI Pharmaceuticals, Inc. The authority of Larry Zhang and Alexander Zukiwski under this Statement shall continue until the undersigned is no longer required to file Forms 4 and 5 with regard to his ownership of or transactions in securities of CASI Pharmaceuticals, Inc., unless earlier revoked in writing. The undersigned acknowledges Larry Zhang and Alexander Zukiwski are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

Date: February 17, 2022

/s/Quan Zhou